Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.
B Hocher, … , W D Schleuning, F Theuring
B Hocher, … , W D Schleuning, F Theuring
Published March 15, 1997
Citation Information: J Clin Invest. 1997;99(6):1380-1389. https://doi.org/10.1172/JCI119297.
View: Text | PDF
Research Article Article has an altmetric score of 3

Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension.

  • Text
  • PDF
Abstract

The human endothelin-1 (ET-1) gene under the control of its natural promoter was transferred into the germline of mice. The transgene was expressed predominantly in the brain, lung, and kidney. Transgene expression was associated with a pathological phenotype manifested by signs such as age-dependent development of renal cysts, interstitial fibrosis of the kidneys, and glomerulosclerosis leading to a progressive decrease in glomerular filtration rate. This pathology developed in spite of only slightly elevated plasma and tissue ET-1 concentrations. Blood pressure was not affected even after the development of an impaired glomerular filtration rate. Therefore, these transgenic lines provide a new blood pressure-independent animal model of ET-1-induced renal pathology leading to renal fibrosis and fatal kidney disease.

Authors

B Hocher, C Thöne-Reineke, P Rohmeiss, F Schmager, T Slowinski, V Burst, F Siegmund, T Quertermous, C Bauer, H H Neumayer, W D Schleuning, F Theuring

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1995 Total
Citations: 4 3 1 4 5 9 6 6 10 13 11 10 9 8 8 9 13 13 11 13 7 13 19 11 19 19 13 17 2 1 287
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2016 (13)

Title and authors Publication Year
Endothelin
AP Davenport, KA Hyndman, N Dhaun, C Southan, DE Kohan, JS Pollock, DM Pollock, DJ Webb, JJ Maguire
Pharmacological reviews 2016
Endothelial dysfunction and vascular disease - a 30th anniversary update
PM Vanhoutte, H Shimokawa, M Feletou, EH Tang
Acta physiologica (Oxford, England) 2016
Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease
R Komers, H Plotkin
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2016
Endothelin‐1 Drives Epithelial‐Mesenchymal Transition in Hypertensive Nephroangiosclerosis
TM Seccia, B Caroccia, F Gioco, M Piazza, V Buccella, D Guidolin, E Guerzoni, B Montini, L Petrelli, E Pagnin, V Ravarotto, AS Belloni, LA Calò, GP Rossi
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2016
Advances in Pharmacology
O Baretella, PM Vanhoutte
Advances in Pharmacology 2016
Heterotrimeric G protein signaling in polycystic kidney disease
T Hama, F Park
Physiological genomics 2016
Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-β1/Smad and GRAP pathways
AS AL-Onazi, NM AL-Rasheed, HA Attia, NM AL-Rasheed, RM Ahmed, MA AL-Amin, C Poizat
Journal of Pharmacy and Pharmacology 2016
Atrasentan Reduces Albuminuria by Restoring the Glomerular Endothelial Glycocalyx Barrier in Diabetic Nephropathy
MG Boels, MC Avramut, A Koudijs, MJ Dane, DH Lee, J der Vlag, AJ Koster, AJ van Zonneveld, E Faassen, HJ Gröne, BM van Berg, TJ Rabelink
Diabetes 2016
Fenofibrate attenuates diabetic nephropathy in experimental diabetic rat's model via suppression of augmented TGF- β 1/Smad3 signaling pathway
NM Al-Rasheed, NM Al-Rasheed, MA Al-Amin, IH Hasan, HN Al-Ajmi, RA Mohammad, HA Attia
Archives Of Physiology And Biochemistry 2016
Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis
R Raina, L Lou, B Berger, B Vogt, AS Do, R Cunningham, P Vasavada, K Herrmann, K Dell, M Simonson
BMC Nephrology 2016
Lack of an apparent role for endothelin‐1 in the prolonged reduction in renal perfusion following severe unilateral ischemia‐reperfusion injury in the mouse
EI Boesen
Physiological Reports 2016
Therapeutic potential of endothelin receptor antagonism in kidney disease
A Czopek, R Moorhouse, DJ Webb, N Dhaun
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2016
Association of Endothelin-1 rs5370 G>T gene polymorphism with the risk of nephrotic syndrome in children
M Hashemi, S Sadeghi-Bojd, S Aryanezhad, M Rezaei
Journal of Nephropathology 2016

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
76 readers on Mendeley
See more details